「Studies on the Enhancement of Antitumor Effect by Drug Combination in Molecular-Targeted Therapy of Cancer」の関連論文
-
Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
-
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma.
-
Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response
-
Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma
-
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
-
Oncogenic E6 and/or E7 proteins drive proliferation and invasion of human papilloma virus‑positive head and neck squamous cell cancer through upregulation of Ror2 expression
-
Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
-
SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization
-
Luteolin suppress bladder cancer growth via regulation of mechanistic target of rapamycin (mTOR) pathway
-
Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma (本文)
-
Vaticanol C, a phytoalexin, induces apoptosis of leukemia and cancer cells by modulating expression of multiple sphingolipid metabolic enzymes
-
Glucose transporter Glut1 controls diffuse invasion phenotype with perineuronal satellitosis in diffuse glioma microenvironment
-
Loss of Arid1a and Pten in Pancreatic Ductal Cells Induces Intraductal Tubulopapillary Neoplasm via the YAP/TAZ Pathway
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models
-
Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPAEnriched Oral Supplement in Advanced Pancreatic Cancer
-
The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B-cell lymphoma and enhances T-cell recruitment
-
Colorectal cancer-derived CAT1-positive extracellular vesicles alter nitric oxide metabolism in endothelial cells and promote angiogenesis
-
miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1
-
The effect of gemcitabine on cell cycle arrest and microRNA signatures in pancreatic cancer cells
-
Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1
-
BMP and activin membrane-bound inhibitor (BAMBI) regulates mesothelioma cell proliferation and clinical outcome
-
BMP and activin membrane-bound inhibitor (BAMBI) regulates mesothelioma cell proliferation and clinical outcome
-
Development of a novel cancer therapy with a ferroptosis inducer and radiation, and a prediction method for therapeutic effects targeting ferroptosis
-
JNK pathway plays a critical role for expansion of human colorectal cancer in the context of BRG1 suppression
-
Inhibition of Dopamine Receptor D1 Signaling Promotes Human Bile Duct Cancer Progression via WNT signaling
-
Preclinical Evaluation of Lymph Node Targeted Therapy in Mouse Models of Cancer
-
Local hyperthermia with built-in endoscopy for radioresistant cervical cancer: a case series
-
Targeting tumor-intrinsic Nuclear Factor-kappa B signaling pathway for the discovery of anti-metastatic drug candidates from natural recourses
-
Annexin A10 is involved in the induction of pancreatic duodenal homeobox-1 in gastric cancer tissue, cells and organoids
-
Annexin A10 is involved in the induction of pancreatic duodenal homeobox-1 in gastric cancer tissue, cells and organoids
-
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells
-
Regulation of Cell Motility by La-Related Protein 4 in Ovarian Cancer Cell
-
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma (本文)
-
Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
-
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors
-
Inhibition of VEGF receptors induces pituitary apoplexy: an experimental study in mice
-
Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer
-
タクロリムスによる神経毒性の発現メカニズムの解明と予防薬の探索
-
Design and Functional Evaluation of Drug Delivery System Based on Dendritic Molecules and Gold Nanorods
-
Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA
-
Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
-
Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
-
Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy
-
Conserved Double Translation Initiation Site for Δ160p53 Protein Hints at Isoform’s Key Role in Mammalian Physiology
-
Core-shell hydrogel microfiber-expanded pluripotent stem cell-derived lung progenitors applicable to lung reconstruction in vivo
-
Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer : A Case Report.
-
Antitumor effect of regorafenib on microRNA expression in hepatocellular carcinoma cell lines
-
Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor